Inari Medical Inc expected to post a loss of 17 cents a share - Earnings Preview

Inari Medical

25/02/2023 03:08

* Inari Medical Inc  NARI.OQ   NARI.O  is expected to show a
rise
in quarterly revenue when it reports  results on February 27. 
    * The Irvine California-based  company is expected to report
 a
26.0% increase in revenue to $104.843 million from $83.22
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
January 10 2023, for the period ended December 31, was for
revenue between $107.00 million and $108.00 million.
    * ​Refinitiv's mean analyst estimate for Inari Medical Inc
is for
a loss of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inari
Medical Inc
is $95.5​, above​ its last closing price of $56.36. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.26       -0.25      -0.19     Beat    25.1
 Jun. 30 2022  -0.23       -0.23      -0.19     Beat    17.4
 Mar. 31 2022  -0.09       -0.09      -0.06     Beat    34.5​
 Dec. 31 2021  0.06        0.03       0.02      Missed  -23.1
 ​​Sep.        -0.21       -0.11      -0.06     Beat    45.5
 30 2021                                                
 Jun. 30 2021  0.09        0.08       0.07      Missed  -14.3​
 Mar. 31 2021  0.07        0.05       0.13      Beat    151.6
 Dec. 31 2020  0.02        0.01       0.13      Beat    875.2
 This summary was machine generated February 25 at 03:08 GMT. 
All figures in US dollars  unless otherwise stated